Inovio reports inducement grants under inducement plan

Plymouth meeting, pa. , may 31, 2024 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-related diseases, cancer, and infectious diseases, today announced that it has made an equity grant to a newly hired employee under its 2022 inducement plan (the "inducement plan").
INO Ratings Summary
INO Quant Ranking